Clinical development plan: Sulindac

Abstract

CAS Name (9CI): (Z)-5-Fluoro-2-methyl-l-(~4-(methylsulfinyl)phenyl)methylene)- 1H-indene-3-acetic AcidSynonyms: Clinoril@' (Active Ingredient) Related Compounds:Sulindac Sulfone (Z)-5-Fluoro-2-methy1-1-((4-methylsulfonyl)phenylmethylene)-1 H-indene-3-acetic Acid FGN-1 Sulindac Sulfide (Z)-5-Fluoro-2-methy1-1-(pmethylthiobenzylidene)-3indenylacetic AcidStructure: 0 EXECUTIVE SUMMARY was discovered in a search for a less toxic version of indomethacin, a structurally related compound. Sulindac is indicated for acute and long-term treatment of the symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, shoulder bursitis/ tendinitis, and acute gouty arthritis at doses of 200 to 400 mg qd (ca. 0.008-0.016 mmol/kg-bw qd) [2].In case studies, sulindac seemed effective in pre-Sulindac is an FDA-approved non-steroidal antiinflammatory (NSAID), antipyretic, and analgesic. As with the other NSAIDs currently being considered by the CB for further development (aspirin, ibuprofen, and piroxicam), sulindac derives its activity from inhibition of cyclooxygenase 11,21. It